C. elegans Expressing Human β2-Microglobulin: A Novel Model for Studying the Relationship between the Molecular Assembly and the Toxic Phenotype

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Diomede, Luisa ^a   Soria, Cristina ^b   Romeo, Margherita ^a   Giorgetti, Sofia ^b   Marchese, Loredana ^b   Mangione, Patrizia Palma ^b,c   Porcari, Riccardo ^b   Zorzoli, Irene ^b   Salmona, Mario ^a   Bellotti, Vittorio ^b,c   Stoppini, Monica ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; TETRACYCLINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LARVAL DEVELOPMENT; MOLECULAR MODEL; OLIGOMERIZATION; PHENOTYPIC VARIATION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RESIDUE ANALYSIS; SEQUENCE ANALYSIS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BETA 2-MICROGLOBULIN; CAENORHABDITIS ELEGANS; FLUORESCENT ANTIBODY TECHNIQUE; GENOTYPE; HUMANS; MICROSCOPY, FLUORESCENCE;

ANIMALIA; CAENORHABDITIS ELEGANS;

EID: 84871356165     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052314     Document Type: Article

References (40)

1. Wolozin B, Gabel C, Ferree A, Guillily M, Ebata A, (2011) Watching worms whither: modeling neurodegeneration in C. elegans. Prog Mol Biol Transl Sci 100: 499-514.
2. Link CD, (2005) Invertebrate models of Alzheimer's disease. Genes Brain Behav 4: 147-156.
3. Lakso M, Vartiainen S, Moilanen AM, Sirviö J, Thomas JH, et al. (2003) Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein. J Neurochem 86: 165-172.
4. Faber PW, Alter JR, MacDonald ME, Hart AC, (1999) Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A 96: 179-184.
5. Luo Y, Wu Y, Brown M, Link CD (2009) Caenorhabditis elegans Model for Initial Screening and Mechanistic Evaluation of Potential New Drugs for Aging and Alzheimer's Disease. In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press; Chapter 16.
6. Alavez S, Vantipalli MC, Zucker DJ, Klang IM, Lithgow GJ, (2011) Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature 1472: 226-229.
7. Liao VH, Yu CW, Chu YJ, Li WH, Hsieh YC, et al. (2011) Curcumin-mediated lifespan extension in Caenorhabditis elegans. Mech Ageing Dev 132: 480-487.
8. Link CD, Johnson CJ, Fonte V, Paupard M, Hall DH, et al. (2001) Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34. Neurobiol Aging 22: 217-226.
9. Link CD, (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A 92: 9368-9372.
10. Zhang P, Fu X, Sawashita J, Yao J, Zhang B, et al. (2010) Mouse model to study human A beta2M amyloidosis: generation of a transgenic mouse with excessive expression of human beta2-microglobulin. Amyloid 17: 50-62.
11. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, et al. (1985) A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 129: 701-706.
12. Corazza A, Pettirossi F, Viglino P, Verdone G, Garcia J, et al. (2004) Properties of some variants of human beta2-microglobulin and amyloidogenesis. J Biol Chem 279: 9176-9189.
13. Fogolari F, Corazza A, Viglino P, Zuccato P, Pieri L, et al. (2007) Molecular dynamics simulation suggests possible interaction patterns at early steps of beta2-microglobulin aggregation. Biophys J 92: 1673-1681.
14. Piazza R, Pierno M, Iacopini S, Mangione P, Esposito G, et al. (2006) Micro-heterogeneity and aggregation in beta2-microglobulin solutions: effects of temperature, pH, and conformational variant addition. Eur Biophys J 35: 439-445.
15. Jahn TR, Parker MJ, Homans SW, Radford SE, (2006) Amyloid formation under physiological conditions proceeds via a native-like folding intermediate. Nat Struct Mol Biol 13: 195-201.
16. Esposito G, Michelutti R, Verdone G, Viglino P, Hernández H, et al. (2000) Removal of the N-terminal hexapeptide from human beta2-microglobulin facilitates protein aggregation and fibril formation. Protein Sci 9: 831-845.
17. Gejyo F, Homma N, Suzuki Y, Arakawa M, (1986) Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 314: 585-586.
18. Hutter H, Vogel BE, Plenefisch JD, Norris CR, Proenca RB, et al. (2000) Conservation and novelty in the evolution of cell adhesion and extracellular matrix genes. Science 287: 989-994.
19. Relini A, De Stefano S, Torrassa S, Cavalleri O, Rolandi R, et al. (2008) Heparin strongly enhances the formation of beta2-microglobulin amyloid fibrils in the presence of type I collagen. J Biol Chem 283: 4912-4920.
20. Giorgetti S, Raimondi S, Pagano K, Relini A, Bucciantini M, et al. (2011) Effect of tetracyclines on the dynamics of formation and destructuration of beta2-microglobulin amyloid fibrils. J Biol Chem 286: 2121-2131.
21. Cardoso I, Saraiva MJ, (2006) Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model. FASEB J 20: 234-239.
22. Diomede L, Cassata G, Fiordaliso F, Salio M, Ami D, et al. (2010) Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers. Neurobiol Dis 40: 424-431.
23. Hoogewijs D, Houthoofd K, Matthijssens F, Vanfleteren JR, (2008) Selection and validation of a set of reliable reference genes for quantitative sod gene expression analysis in C. elegans. BMC Mol Biol 22: 9: 9.
24. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
25. Finney M, Ruvkun G, (1990) The unc-86 gene product couples cell lineage and cell identity in C. elegans. Cell 63: 895-905.
26. Miller DM, Shakes DC, (1995) Immunofluorescence microscopy. Methods Cell Biol 48: 365-394.
27. Choi HS, Kim JW, Cha YN, Kim C, (2006) A quantitative nitroblue tetrazolium assay for determining intracellular superoxide anion production in phagocytic cells. J Immunoassay & Immunochemistry 27: 31-44.
28. Byerly L, Cassada RC, Russell RL, (1976) The life cycle of the nematode Caenorhabditis elegans. I. Wild-type growth and reproduction. Dev Biol 51: 23-33.
29. Luo Y, (2006) Alzheimer's disease, the nematode Caenorhabditis elegans, and ginko biloba leaf extract. Life Sci 78: 2066-2072.
30. Gutierrez-Zepeda A, Santell R, Wu Z, Brown M, Wu Y, et al. (2005) Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci 6: 54-62.
31. Stoppini M, Mangione P, Monti M, Giorgetti S, Marchese L, et al. (2005) Proteomics of beta2-microglobulin amyloid fibrils. Biochim Biophys Acta 1753: 23-33.
32. Eichner T, Kalverda AP, Thompson GS, Homans SW, Radford SE, (2011) Conformational conversion during amyloid formation at atomic resolution. Mol Cell 41: 161-172.
33. Monti M, Amoresano A, Giorgetti S, Bellotti V, Pucci P, (2005) Limited proteolysis in the investigation of beta2-microglobulin amyloidogenic and fibrillar states. Biochim Biophys Acta 1753: 44-50.
34. Tsang WY, Lemire BD, (2003) The role of mitochondria in the life of the nematode, Caenorhabditis elegans. Biochim Biophys Acta 1638: 91-105.
35. Pagani L, Eckert A, (2011) Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis 2011: 925050.
36. Meratan AA, Ghasemi A, Nemat-Gorgani M, (2011) Membrane integrity and amyloid cytotoxicity: a model study involving mitochondria and lysozyme fibrillation products. J Mol Biol 409: 826-838.
37. Gama Sosa MA, De Gasperi R, Elder GA, (2012) Modeling human neurodegenerative diseases in transgenic systems. Hum Genet 131: 535-563.
38. Prahdal V, Morimoto RI, (2011) Neuronal circuitry regulates the response of Caenorhabditis elegans to misfolded proteins. Proc Natl Acad Sci U S A 108: 14204-14209.
39. Valleix S, Gillmore JD, Bridoux F, Mangione PP, Dogan A, et al. (2012) Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin. N Engl J Med 366: 2276-2283.
40. Domanska K, Vanderhaegen S, Srinivasan V, Pardon E, Dupeux F, et al. (2011) Atomic structure of a nanobody-trapped domain-swapped dimer of an amyloidogenic beta2-microglobulin variant. Proc Natl Acad Sci U S A 108: 1314-1319.